AR052258A1 - DERIVATIVES OF PHENYLPIPERAZINES WITH A COMBINED AFFINITY FOR DOPAMINE - D2 RECEPTORS AND SEROTONINE REABSORTION SITES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS MEDICINES FOR THE TREATMENT OF NERVIO SYSTEMS. - Google Patents
DERIVATIVES OF PHENYLPIPERAZINES WITH A COMBINED AFFINITY FOR DOPAMINE - D2 RECEPTORS AND SEROTONINE REABSORTION SITES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS MEDICINES FOR THE TREATMENT OF NERVIO SYSTEMS.Info
- Publication number
- AR052258A1 AR052258A1 ARP050105090A ARP050105090A AR052258A1 AR 052258 A1 AR052258 A1 AR 052258A1 AR P050105090 A ARP050105090 A AR P050105090A AR P050105090 A ARP050105090 A AR P050105090A AR 052258 A1 AR052258 A1 AR 052258A1
- Authority
- AR
- Argentina
- Prior art keywords
- dopamine
- receptors
- derivatives
- unbranched
- branched
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title abstract 3
- 102000004980 Dopamine D2 Receptors Human genes 0.000 title abstract 2
- 108090001111 Dopamine D2 Receptors Proteins 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical class C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009103 reabsorption Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Derivados de fenilpiperazina con un doble modo de accion, inhibicion de la reabsorcion de la serotonina y afinidad para receptores de dopamina-D2. Uso de estos compuestos para la fabricacion de un medicamento que tiene un efecto beneficioso para el SNC. Reivindicacion 1: Compuestos de fenilpiperazina, caracterizados por la formula general (1) donde: m y n son independientemente 1, 2, 3, 4, 5, 6, 7 u 8; x es 0, 1, 2 o 3, R2 es halogeno, alquilo C1-6 ramificado o no ramificado, fenilo, bencilo, alcoxi C1-6 ramificado o no ramificado, trifluorometilo o ciano; R3 y R4 representan independientemente H, alquilo C1-6, fenilo, bencilo o acetilo; el grupo Q se selecciona entre los fragmentos estructurales A-N donde: y es 1, 2 o 3; R1 es halogeno, alquilo C1-6 ramificado o no ramificado, fenilo, bencilo, alcoxi C1-6 ramificado o no ramificado, trifluorometilo o ciano; y los tautomeros, estereoisomeros y N-oxidos de los mismos, como así también las sales, hidratos y solvatos farmacologicamente aceptables de dichos compuestos de formula (1) y sus tautomeros, estereoisomeros y N-oxidos.Phenylpiperazine derivatives with a double mode of action, inhibition of serotonin reabsorption and affinity for dopamine-D2 receptors. Use of these compounds for the manufacture of a medicament that has a beneficial effect on the CNS. Claim 1: Phenylpiperazine compounds, characterized by the general formula (1) wherein: m and n are independently 1, 2, 3, 4, 5, 6, 7 or 8; x is 0, 1, 2 or 3, R2 is halogen, branched or unbranched C1-6 alkyl, phenyl, benzyl, branched or unbranched C1-6 alkoxy, trifluoromethyl or cyano; R3 and R4 independently represent H, C1-6 alkyl, phenyl, benzyl or acetyl; group Q is selected from structural fragments A-N where: y is 1, 2 or 3; R1 is halogen, branched or unbranched C1-6 alkyl, phenyl, benzyl, branched or unbranched C1-6 alkoxy, trifluoromethyl or cyano; and the tautomers, stereoisomers and N-oxides thereof, as well as the pharmacologically acceptable salts, hydrates and solvates of said compounds of formula (1) and their tautomers, stereoisomers and N-oxides.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106350 | 2004-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052258A1 true AR052258A1 (en) | 2007-03-07 |
Family
ID=34930004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050105090A AR052258A1 (en) | 2004-12-07 | 2005-12-06 | DERIVATIVES OF PHENYLPIPERAZINES WITH A COMBINED AFFINITY FOR DOPAMINE - D2 RECEPTORS AND SEROTONINE REABSORTION SITES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS MEDICINES FOR THE TREATMENT OF NERVIO SYSTEMS. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1828161A2 (en) |
JP (1) | JP2008523026A (en) |
KR (1) | KR20070091646A (en) |
CN (1) | CN101072765A (en) |
AR (1) | AR052258A1 (en) |
AU (1) | AU2005313386A1 (en) |
BR (1) | BRPI0518370A2 (en) |
CA (1) | CA2587928A1 (en) |
MX (1) | MX2007006756A (en) |
RU (1) | RU2007125636A (en) |
SA (1) | SA05260389B1 (en) |
TW (1) | TW200633987A (en) |
WO (1) | WO2006061372A2 (en) |
ZA (1) | ZA200704151B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8106056B2 (en) | 2006-06-16 | 2012-01-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising bifeprunox and a dopamine agonist |
US8063062B2 (en) | 2006-12-20 | 2011-11-22 | Solvay Pharmaceuticals B.V. | Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition |
US8138174B2 (en) | 2007-01-10 | 2012-03-20 | Solvay Pharmaceuticals B.V. | Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition |
EA200970672A1 (en) * | 2007-01-10 | 2010-02-26 | Солвей Фармасьютикалс Б.В. | CONNECTIONS WITH THE COMBINATION OF CANNABINOID-SWANTAGONISM AND INHIBITION OF SEROTONIN REVERSE CAPTURE |
AU2009204851A1 (en) * | 2008-01-15 | 2009-07-23 | Abbott Healthcare Products B.V. | Bifeprunox derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2162312B1 (en) * | 1971-12-10 | 1975-02-07 | Buzas Andre | |
ATE81975T1 (en) * | 1984-12-21 | 1992-11-15 | Duphar Int Res | MEDICATIONS WITH PSYCHOTROPIC EFFECTS. |
TR200200460T2 (en) * | 1999-08-23 | 2002-06-21 | Solvay Pharmaceuticals B.V. | New phenylpiperazines |
AR032712A1 (en) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | A MESILATE OF PHENYLPIPERAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
-
2005
- 2005-12-06 BR BRPI0518370-7A patent/BRPI0518370A2/en not_active IP Right Cessation
- 2005-12-06 TW TW094142933A patent/TW200633987A/en unknown
- 2005-12-06 WO PCT/EP2005/056500 patent/WO2006061372A2/en active Application Filing
- 2005-12-06 KR KR1020077015625A patent/KR20070091646A/en not_active Application Discontinuation
- 2005-12-06 CN CNA2005800420702A patent/CN101072765A/en active Pending
- 2005-12-06 SA SA05260389A patent/SA05260389B1/en unknown
- 2005-12-06 CA CA002587928A patent/CA2587928A1/en not_active Abandoned
- 2005-12-06 EP EP05819231A patent/EP1828161A2/en not_active Withdrawn
- 2005-12-06 JP JP2007544892A patent/JP2008523026A/en not_active Withdrawn
- 2005-12-06 MX MX2007006756A patent/MX2007006756A/en unknown
- 2005-12-06 RU RU2007125636/04A patent/RU2007125636A/en not_active Application Discontinuation
- 2005-12-06 AU AU2005313386A patent/AU2005313386A1/en not_active Abandoned
- 2005-12-06 AR ARP050105090A patent/AR052258A1/en not_active Application Discontinuation
-
2007
- 2007-05-22 ZA ZA200704151A patent/ZA200704151B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005313386A1 (en) | 2006-06-15 |
JP2008523026A (en) | 2008-07-03 |
BRPI0518370A2 (en) | 2008-11-18 |
WO2006061372A2 (en) | 2006-06-15 |
CA2587928A1 (en) | 2006-06-15 |
MX2007006756A (en) | 2007-11-09 |
RU2007125636A (en) | 2009-01-20 |
WO2006061372A3 (en) | 2006-11-23 |
ZA200704151B (en) | 2008-08-27 |
CN101072765A (en) | 2007-11-14 |
TW200633987A (en) | 2006-10-01 |
EP1828161A2 (en) | 2007-09-05 |
SA05260389B1 (en) | 2009-06-09 |
KR20070091646A (en) | 2007-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20061298A1 (en) | DIHYDROBENZOFURAN-DERIVED COMPOUNDS AS AGONISTS OF THE SEROTONIN 5-HT2C RECEPTOR | |
UY29393A1 (en) | NEW DERIVATIVES OF AMIDAS, ACCEPTABLE PHARMACEUTICAL SALTS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS. | |
NI200700270A (en) | BENZODIOXAN AND BENZODIOXOLAN DERIVATIVES AND USES OF THE SAME | |
AR066583A1 (en) | DERIVATIVES OF 3,3-ESPIROINDOLINONA | |
AR062209A1 (en) | MGLUR5 METABOTROPIC GLUTAMATE RECEPTORS MODULATING PIRAZOLOPIRIMIDINES, PROCESS FOR PREPARATION, MEDICATIONS CONTAINING THEM AND USES IN THE PREVENTION AND / OR TREATMENT OF ACUTE AND CHRONIC NEUROLOGICAL DISORDERS. | |
AR064561A1 (en) | DERIVATIVES OF 2-AZA-BICYCLE [3.1.0] HEXANE AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES RELATED TO GENERAL DYSFUNCTIONS OF THE OREXINE SYSTEM. | |
ATE496620T1 (en) | 1H-BENZO(F)INDAZOLE-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | |
AR062683A1 (en) | COMPOUNDS DERIVED FROM PIRIDIN-4-ILO, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE OF THE SAME IN THE PREPARATION OF MEDICINES | |
AR078045A1 (en) | PIRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER | |
ECSP034831A (en) | SUBSTITUTED DERIVATIVES OF 2-PYRIDINE CYCLHEXAN-1,4-DIAMINE | |
UY29312A1 (en) | PIPERAZIN-1-CARBOXAMIDAS N, 4, SUBSTITUTES AND THEIR DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS | |
UY28765A1 (en) | ACETILINIC PIPERAZINE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEPTOR | |
CR7566A (en) | DERIVATIVES OF 1- (AMINOALQUIL) -3-SULFONYLINDOL AND 1-AMINOALQUIL-3-SULFONYLINDAZOL AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS | |
EA200300619A1 (en) | SEROTONINERGIC MEANS | |
AR063147A1 (en) | INHIBITING NITROGEN HETEROCICLIC COMPOUNDS OF HISTAMINE H3 RECEPTORS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS. | |
UY29739A1 (en) | DERIVATIVES OF AMIDAS OR PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PROCESSES OF PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND APPLICATIONS | |
AR052258A1 (en) | DERIVATIVES OF PHENYLPIPERAZINES WITH A COMBINED AFFINITY FOR DOPAMINE - D2 RECEPTORS AND SEROTONINE REABSORTION SITES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS MEDICINES FOR THE TREATMENT OF NERVIO SYSTEMS. | |
AR056175A1 (en) | CHROMAN COMPOUNDS AS 5-HT1B ANTAGONISTS | |
NO20054225L (en) | Benzamide derivatives such as oxytocin agonists and vasopressin antagonists | |
MX2010003849A (en) | Cgrp antagonists. | |
AR069607A1 (en) | INHIBITORS OF THE ESTEAROIL-COA DESATURASA | |
AR045793A1 (en) | COMPOUNDS DERIVED FROM 3-HETEROCICLIL-INDOL | |
AR077301A1 (en) | DERIVATIVES OF 2-CARBOXAMIDA-7-PIPERAZINIL-BENZOFURAN AS ANTAGONISTS OF 5-HT1A AND 5-HT1B | |
CO5660263A2 (en) | DERIVATIVES OF IMIDAZOL HETEROARIL SUBSTITUTED AS ANTAGONISTS OF THE GLUTAMATE RECEIVER | |
AR028743A1 (en) | DERIVATIVES OF N-TRIAZOLILMETIL-PIPERAZINA WITH ANTAGONIST ACTION OF NEUROQUININE RECEPTORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |